2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$4.64+$0.010 (+0.22%)
Price as of Aug 21, 2026 7:30 PM EDT- $493.9MMarket Cap
- 638.44%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$4.64+$0.010 (+0.22%)
Earnings Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -26.03% | ||
12-Month Momentum | 752.46% | ||
3-Month Risk Adjusted Momentum | -100.55% | ||
12-Month Risk Adjusted Momentum | 645.24% |
True Yield
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 1.35% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |